PetVivo Partners with Commonwealth to Champion Equine Health
PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a forward-thinking biomedical device company, has recently announced an exciting collaboration with Commonwealth, a renowned ownership group known for its success in thoroughbred racing. Together, they aim to promote better equine health, specifically targeting the joint wellness of racehorses through innovative solutions.
Introduction to SPRYNG and PrecisePRP Technology
The collaboration leverages PetVivo’s advanced technologies, namely SPRYNG with OsteoCushion Technology, an intra-articular device designed to enhance joint durability and health. Additionally, they will incorporate PrecisePRP, a first-of-its-kind off-the-shelf platelet-rich plasma (PRP) product specially tailored for elite equine athletes.
The Benefits of Effective Joint Health Solutions
With the integration of these cutting-edge products, Commonwealth will utilize SPRYNG and PrecisePRP within its care protocols for top-performing thoroughbreds. This strategic use emphasizes both prevention and treatment to ensure that these athletes maintain their peak performance, longevity, and quick recovery during rigorous training and competitive settings.
Educational Initiatives and Industry Outreach
Beyond the technology’s clinical application, the partnership will explore opportunities for creating educational content and industry outreach initiatives. This will help to increase awareness regarding the importance of joint health, ensuring that more equine caretakers and veterinarians adopt the revolutionary benefits of SPRYNG and PrecisePRP.
A Word from the Leadership at PetVivo
John Lai, the CEO of PetVivo, expressed his excitement about the partnership, noting, "Working with Commonwealth, a recognized leader in this elite arena, marks a pivotal achievement for both SPRYNG and PrecisePRP. Their commitment to championing equine wellness aligns perfectly with our mission to promote scientifically sound health practices for horses. Together, we aspire to reshape equine health care, making it more effective and accessible."
Commonwealth’s Dedication to Equine Welfare
Chase Chamberlin, the CEO of Commonwealth, shared his enthusiasm about the partnership, stressing the importance of innovations like SPRYNG and PrecisePRP in enhancing horse safety and performance. "Our mission is to uphold the safety of our equine athletes, and with new welfare protocols from HISA in play, this collaboration allows us to minimize injury risks while maximizing performance. We're thrilled to integrate PetVivo's advanced treatments into our framework," he noted.
Significance of this Partnership
The collaboration signifies a major advancement in the commitment to improve equine health through effective and innovative strategies. Mike Eldred, a Board Director at PetVivo, remarked on the significance of this joint effort, emphasizing how it bolsters their goal to lead the market in equine joint health and regenerative solutions. By merging their clinical expertise with Commonwealth’s extensive industry knowledge, they aim to provide veterinarians with state-of-the-art, effective treatment options that can significantly enhance recovery and ensure long-term soundness in competitive horses.
About Commonwealth and its Vision
Commonwealth is known for revolutionizing the thoroughbred racing experience by offering fans the unique opportunity to own equity shares in racehorses. With minimum stakes as low as $50, this platform not only makes thrilling horse racing accessible but also fosters a deep connection between fans and the sport. Their roster includes celebrated champions like the 2023 Kentucky Derby winner Mage and the notable 2022 Dubai World Cup Champion, Country Grammer.
PetVivo's Commitment to Animal Health
PetVivo Holdings specializes in creating and marketing innovative biomedical devices for companion animals. Their portfolio features an impressive array of patents and proprietary technologies aimed at improving the lives of pets—whether through joint health solutions like SPRYNG or groundbreaking products like PrecisePRP.
Frequently Asked Questions
What technologies are PetVivo and Commonwealth partnering on?
The partnership focuses on SPRYNG with OsteoCushion Technology and PrecisePRP, both aimed at enhancing equine joint health.
How will these products benefit thoroughbred racing?
These technologies are designed to support joint health, extend performance longevity, and aid recovery in racehorses.
Who are the key leaders in this partnership?
John Lai from PetVivo and Chase Chamberlin from Commonwealth are the key executives driving this collaboration.
What is Commonwealth's mission?
Commonwealth aims to enhance equine athlete welfare while providing thrilling ownership experiences for fans.
How can I learn more about PetVivo's products?
For more information, visit PetVivo's official website and connect with their products designed for animal health.
